drugset / Trial / NCT00525278

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

NCT00525278

Phase 3 Completed 67 enrolled UCB Pharma
RandomizedParallel-groupSingle-blindTreatment

Summary

To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis

Timeline

Start
2003-08
Primary completion
2003-10
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 5 mg Oral